Health Economics & Outcomes Research Associate Director, Cell & Gene Therapy

General Summary: Vertex seeks a Health Economics & Outcomes Research Associate Director, Cell and Gene Therapy (CGT) to lead development and execution of HEOR studies supporting CGT products in hemoglobinopathies and type 1 diabetes. Reports to the Senior Director Global HEOR, CGT. Key Duties And Responsibilities: Lead others executing complex HEOR evidence generation: cost-effective analyses and budget impact models; prospective and retrospective observational studies; ITCs; meta-analyses and systematic reviews; patient-reported outcome measure development/validation; and other research to support asset value. Gather and synthesize payer, KOL, and HEOR expert insights; stay current on scientific/policy trends and apply to strategy planning. Provide key input using best practices to design Vertex observational research studies. Collaborate with medical communications on publication strategy; ensure timely, high-impact dissemination of HEOR evidence. Partner with Global Value and Access Strategy to support production of GVD and Value Narrative. Knowledge And Skills: Strong publication track record in peer-reviewed journals. Technical HEOR expertise; ability to formulate/lead rigorous, best-practice HEOR research. Strong written and verbal communication skills, including presenting and persuading across audiences. Ability to apply US healthcare system and global health technology appraisal requirements, and clinical development knowledge to identify evidence gaps and develop evidence generation strategies. Understanding of pharmaceutical industry legal/regulatory environment and compliance. Education And Experience: Advanced degree (PhD, MD, Master’s, MPH, or PharmD) in a relevant discipline. Typically 8 years of experience with substantial HEOR background (or equivalent). Prior cell/gene therapy and/or hemoglobinopathies and type 1 diabetes experience preferred. Pay Range: $176,000 - $264,000 #J-18808-Ljbffr Scorpion Therapeutics